ArticleCrohn's & colitis 3602026
Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's disease.
Evan N Fear et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it